This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Another Challenge to China's Growth
Fatás, Antonio; Mihov, IlianArticle HBS-F0903B-EStrategyBelow $10,000 per capita, a country's income can grow even in the absence of good institutions. But at higher income levels, as China will soon discover, institutional quality starts to matter quite a lot.Starting at €8.20
-
PerkinElmer - Developing Products in China for China
Sato, Vicki L.; Jaeker, Christoph; Reda, KareemCase HBS-612032-EService and Operations ManagementTo maximize their effectiveness, color cases should be printed in color. Sym-Bio, an entrepreneurial Chinese diagnostic company with a product line in infectious disease testing, has agreed to be acquired by PerkinElmer, an international corporation with businesses in neonatal testing, life science services, and environmental health. Sym-Bio wants to accelerate its growth and competitive position in China through this strategic move, and PerkinEl...Starting at €8.20
-
BGI: Data-driven Research
Shih, Willy; Chai, SenCase HBS-614056-EService and Operations ManagementBGI has the largest installed gene-sequencing capacity in the world, and to Zhang Gengyun, general manager of the Life Sciences Division, this represented an opportunity to apply his training as a plant breeder and his early career work as a biochemist to improving important parts of the world food supply. But his biggest challenge was in scaling up his organization to address the multitude of opportunities he wanted to address. Along with its ma...Starting at €8.20
-
Dalian Wanda Group: The AMC Entertainment Acquisition (A)
Shih, WillyCase HBS-615033-EStrategyWhen Dalian Wanda Group of China announced its plan to acquire the AMC Entertainment theatrical exhibition chain in the United States, many people in the U.S were mystified. Unlike China where theatrical exhibition was experiencing rapid growth, the U.S. market was viewed as mature, and rapidly changing technology was giving consumers a widening range of choices for movie viewing. AMC was owned by a group of private equity firms, and their pessim...Starting at €8.20
-
Baidu, Alibaba, and Tencent: The Three Kingdoms of the Chinese Internet
Zhu, Feng; Smith, AaronCase HBS-615039-EService and Operations ManagementThis note provides an overview of the Chinese Internet by describing its leading three companies: Baidu, Alibaba, and Tencent (BAT). While BAT had previously focused their respective businesses on distinct sectors of the online economy-Baidu for search, Alibaba for e-commerce, and Tencent for games and instant messaging-the proliferation of mobile devices in China introduced new territory to be conquered. By the end of 2014, BAT had each made a s...Starting at €8.20
-
SF Express: From Delivery to E-Commerce
Zhu, Feng; Lane, DavidCase HBS-616003-EService and Operations ManagementShunfeng Express (SF), China's leading express delivery firm, in May 2014 opened the first 500 of several thousand Heike stores, which allowed consumers to buy and try out SF's own e-commerce offerings, in addition to other services. As an example of China's "online-to-offline" trend in e-commerce, Heike stores allowed SF to leverage its logistics and IT expertise to differentiate itself from its rivals in express delivery. As yet unclear was whe...Starting at €8.20
-
SF Express: From Delivery to E-Commerce, Teaching Note
Zhu, FengTeaching Note HBS-616018-EService and Operations ManagementTeaching note for case 616003.Starting at €0.00
-
Bayern Munich in China
Lakhani, Karim R.; Schmidt, Sascha L.; Norris, Michael; Herman, KerryCase HBS-617025-EService and Operations ManagementIn 2015, German football club Bayern Munich is considering how to enter the Chinese market. Should it build its own infrastructure or rely on third-party partnerships to reach this massive football fanbase?Starting at €8.20
-
BeiGene
Shih, Willy; Zhang, JimmyCase HBS-618033-EStrategyBeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeStarting at €8.20
-
BeiGene, PowerPoint Supplement
Shih, Willy; Zhang, JimmyCase HBS-618043-EStrategyPowerPoint slides for case 618033.Starting at €8.20